Ropivacaine + Bupivacaine

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anesthesia,Spinal

Conditions

Anesthesia,Spinal

Trial Timeline

Apr 1, 2006 โ†’ Sep 1, 2006

About Ropivacaine + Bupivacaine

Ropivacaine + Bupivacaine is a phase 3 stage product being developed by AstraZeneca for Anesthesia,Spinal. The current trial status is completed. This product is registered under clinical trial identifier NCT00358280. Target conditions include Anesthesia,Spinal.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00358280Phase 3Completed

Competing Products

20 competing products in Anesthesia,Spinal

See all competitors